How to Help Your Patients Save Money on Baqsimi: A Provider's Guide to Savings Programs

Baqsimi (glucagon nasal powder 3 mg) is an essential rescue medication for insulin-using patients with diabetes — but at $300-$400 per device with no generic available, cost is one of the most common reasons patients fail to fill the prescription you've written for them. Studies consistently show that patients who don't fill an emergency medication prescription at the time of prescribing are unlikely to fill it later.

This guide is designed to help you address Baqsimi cost barriers proactively — at the point of care — so your patients leave your office with both a prescription and a realistic plan to fill it.

The Baqsimi Cost Landscape in 2026

Understanding what patients actually pay — and what's available to help — is the first step:

Retail (cash, no coupon): ~$300-$401 per One Pack device; ~$817 for Two Pack.

With manufacturer savings card (commercially insured): As little as $25 for up to 2 devices.

With patient assistance program (uninsured, low income): $0 for qualifying patients.

With prescription discount cards (GoodRx, SingleCare): ~$280-$560 depending on pharmacy and program tier.

No generic available: As of early 2026, no FDA-approved generic version exists.

Program 1: Baqsimi Got Your BAQ Savings Card

The single most impactful intervention for commercially insured patients is ensuring they have the Baqsimi manufacturer's savings card:

Program: Baqsimi Got Your BAQ Savings Card

Managed by: Amphastar Pharmaceuticals | Phone: 1-800-423-4136

Benefit: As little as $25 for up to 2 Baqsimi devices per prescription fill.

Eligibility: Must have commercial drug insurance coverage for Baqsimi.

Limits: Up to 12 fills per year; annual savings cap of $1,800.

NOT available for: Medicare, Medicaid, TRICARE, VA, or other government payers.

Provider recommendation: Print or include the savings card URL (baqsimi.com/savings-resources) in your after-visit summary for every Baqsimi prescription issued to a commercially insured patient.

Program 2: Lilly Cares Patient Assistance Program (PAP)

For your uninsured or underinsured patients, the Lilly Cares PAP remains available and can provide Baqsimi at no cost to qualifying individuals:

Program: Lilly Cares Foundation Patient Assistance Program

Phone: 1-800-545-6962 | Website: lillycares.com

Benefit: Baqsimi at no cost to qualifying patients.

Eligibility: Most uninsured patients with annual income up to approximately $40,000 qualify.

Authorization duration: 1 year, renewable.

Provider recommendation: Have your office manager or medical assistant prepare and submit Lilly Cares applications for appropriate patients, or hand them a pre-printed instructions sheet at checkout. PAP applications typically require the provider's signature.

Program 3: Prescription Discount Cards (GoodRx, SingleCare)

For patients who don't qualify for the manufacturer savings card (e.g., government insurance beneficiaries), prescription discount cards can still provide meaningful savings:

GoodRx: GoodRx has partnered with Inside RX and Lilly on Baqsimi pricing. GoodRx Gold may offer the lowest available cash price (~$280-$560 at various pharmacies).

SingleCare: Reduces One Pack to ~$280 at participating pharmacies (CVS, Walgreens, Walmart, Kroger).

These discount cards cannot be combined with insurance — advise patients to compare the discount card price vs. their insurance copay at the specific pharmacy they use, and choose whichever is lower.

Insurance Strategy: Prior Authorization and Formulary Navigation

Baqsimi's formulary tier placement varies by payer. Strategies to optimize insurance coverage:

Check formulary before prescribing: Use your EHR's formulary checker to determine if Baqsimi is covered, at what tier, and whether PA is required.

Submit PA proactively: If PA is anticipated, file it at the same time as the prescription. Document: needle-free delivery necessity, caregiver training limitations, or history of hypoglycemia.

Tier exception request: If Baqsimi is on Tier 3, submit a tier exception request citing medical necessity for the nasal route — particularly for patients with needle phobia, dexterity limitations, or pediatric patients.

Consider alternatives if coverage is better: If your patient's plan covers Gvoke or Zegalogue at Tier 1 or 2 with no PA, and the patient is comfortable with injections, a therapeutic substitution may be the most practical path to ensuring they have rescue glucagon.

Building a Savings Program Workflow Into Your Practice

For high-volume practices, consider these workflow integrations:

Add Baqsimi savings card to your After Visit Summary template for all insulin-using patients.

Pre-load Baqsimi PA templates with standard medical necessity language in your EHR.

Designate one staff member to follow up on Baqsimi prescriptions 2 days after visit to confirm they were filled.

Ask patients at every follow-up: "Do you still have Baqsimi? When does it expire?"

Use medfinder to help patients locate a pharmacy with Baqsimi in stock when they report availability issues.

Addressing Medicare Patients

Medicare generally does not cover Baqsimi, which is a significant barrier for elderly patients. Key options for Medicare patients:

Medicare Extra Help (Low-Income Subsidy): For patients with limited income and resources, this program provides additional Part D cost assistance. Refer patients to 1-800-772-1213 (Social Security) to apply.

State Pharmaceutical Assistance Programs (SPAPs): Some states supplement Medicare coverage for high-cost medications. Check your state's SPAP availability.

Alternative glucagon: For Medicare patients who absolutely cannot access Baqsimi, consider prescribing Gvoke or Zegalogue — check those plans' formularies as well.

The Clinical Case for Investing Time in Baqsimi Access

An untreated severe hypoglycemia episode can result in seizure, coma, cardiac arrest, or death. Patients who don't have rescue glucagon on hand are at significantly greater risk. The 5-10 minutes spent at the point of prescribing — connecting patients to savings programs, submitting PAs, and recommending medfinder for stock searches — is among the highest-value preventive care activities in a diabetes practice. Visit medfinder.com/providers to learn more about how medfinder supports provider workflows for medication access.

For the clinical side of availability navigation, see our provider guide on Baqsimi shortage: what providers and prescribers need to know in 2026.